CVE-2026-24164

CRITICALCVSS 9.8/10EPSS 0.47%

Last modified

CVE-2026-24164 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.. EPSS estimates a 0.47% chance of exploitation in the next 30 days.

Description

NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

Metrics

CVSS 3.1
9.8/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
0.47%

37.3th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
NvidiaBionemo Framework< 2026-01-21

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-24164?
NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
How severe is CVE-2026-24164?
CVE-2026-24164 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 0.47% probability of exploitation in the next 30 days.
How do I fix CVE-2026-24164?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2026-24164?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST